324 related articles for article (PubMed ID: 37175602)
1. Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine.
Cohen CF; Roh J; Lee SH; Park CK; Berta T
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175602
[TBL] [Abstract][Full Text] [Related]
2. The role of TRP ion channels in migraine and headache.
Iannone LF; De Logu F; Geppetti P; De Cesaris F
Neurosci Lett; 2022 Jan; 768():136380. PubMed ID: 34861342
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF.
Giniatullin R; Nistri A; Fabbretti E
Mol Neurobiol; 2008 Feb; 37(1):83-90. PubMed ID: 18459072
[TBL] [Abstract][Full Text] [Related]
4. The role of chemosensitive afferent nerves and TRP ion channels in the pathomechanism of headaches.
Dux M; Sántha P; Jancsó G
Pflugers Arch; 2012 Sep; 464(3):239-48. PubMed ID: 22875278
[TBL] [Abstract][Full Text] [Related]
5. TRPA1 and other TRP channels in migraine.
Benemei S; De Cesaris F; Fusi C; Rossi E; Lupi C; Geppetti P
J Headache Pain; 2013 Aug; 14(1):71. PubMed ID: 23941062
[TBL] [Abstract][Full Text] [Related]
6. Nucleotide homeostasis and purinergic nociceptive signaling in rat meninges in migraine-like conditions.
Yegutkin GG; Guerrero-Toro C; Kilinc E; Koroleva K; Ishchenko Y; Abushik P; Giniatullina R; Fayuk D; Giniatullin R
Purinergic Signal; 2016 Sep; 12(3):561-74. PubMed ID: 27369815
[TBL] [Abstract][Full Text] [Related]
7. Implications of Transient Receptor Potential Cation Channels in Migraine Pathophysiology.
Shibata M; Tang C
Neurosci Bull; 2021 Jan; 37(1):103-116. PubMed ID: 32870468
[TBL] [Abstract][Full Text] [Related]
8. Mechanosensitive meningeal nociception via Piezo channels: Implications for pulsatile pain in migraine?
Mikhailov N; Leskinen J; Fagerlund I; Poguzhelskaya E; Giniatullina R; Gafurov O; Malm T; Karjalainen T; Gröhn O; Giniatullin R
Neuropharmacology; 2019 May; 149():113-123. PubMed ID: 30768945
[TBL] [Abstract][Full Text] [Related]
9. TRP Channels in the Focus of Trigeminal Nociceptor Sensitization Contributing to Primary Headaches.
Dux M; Rosta J; Messlinger K
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948011
[TBL] [Abstract][Full Text] [Related]
10. Targeting TRP channels for novel migraine therapeutics.
Dussor G; Yan J; Xie JY; Ossipov MH; Dodick DW; Porreca F
ACS Chem Neurosci; 2014 Nov; 5(11):1085-96. PubMed ID: 25138211
[TBL] [Abstract][Full Text] [Related]
11. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats.
Ma QP; Hill R; Sirinathsinghji D
Eur J Neurosci; 2001 Jun; 13(11):2099-104. PubMed ID: 11422450
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of migraine--new insights.
Hargreaves RJ; Shepheard SL
Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S12-9. PubMed ID: 10563228
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons.
Buldyrev I; Tanner NM; Hsieh HY; Dodd EG; Nguyen LT; Balkowiec A
J Neurochem; 2006 Dec; 99(5):1338-50. PubMed ID: 17064360
[TBL] [Abstract][Full Text] [Related]
14. Testing the Role of Glutamate NMDA Receptors in Peripheral Trigeminal Nociception Implicated in Migraine Pain.
Guerrero-Toro C; Koroleva K; Ermakova E; Gafurov O; Abushik P; Tavi P; Sitdikova G; Giniatullin R
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163452
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.
Haanes KA; Edvinsson L
CNS Drugs; 2019 Jun; 33(6):525-537. PubMed ID: 30989485
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Connections of the TRPA1 Ion Channel in Pain Transmission and Neurogenic Inflammation - a Therapeutic Perspective in Migraine?
Fila M; Pawlowska E; Szczepanska J; Blasiak J
Mol Neurobiol; 2023 Oct; 60(10):5578-5591. PubMed ID: 37326902
[TBL] [Abstract][Full Text] [Related]
17. Local action of the proinflammatory cytokines IL-1β and IL-6 on intracranial meningeal nociceptors.
Zhang X; Burstein R; Levy D
Cephalalgia; 2012 Jan; 32(1):66-72. PubMed ID: 22144718
[TBL] [Abstract][Full Text] [Related]
18. Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain.
Kilinc E; Guerrero-Toro C; Zakharov A; Vitale C; Gubert-Olive M; Koroleva K; Timonina A; Luz LL; Shelukhina I; Giniatullina R; Tore F; Safronov BV; Giniatullin R
Neuropharmacology; 2017 Apr; 116():160-173. PubMed ID: 28025094
[TBL] [Abstract][Full Text] [Related]
19. Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.
Durham PL; Masterson CG
Headache; 2013 Jan; 53(1):67-80. PubMed ID: 23095108
[TBL] [Abstract][Full Text] [Related]
20. Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain.
Tajti J; Szok D; Csáti A; Szabó Á; Tanaka M; Vécsei L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
